Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
16 hedge funds and large institutions have $39.5M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
18% less capital invested
Capital invested by funds: $47.9M → $39.5M (-$8.4M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$393K |
| 2 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
+$29.2K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
+$10.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.97K |
| 5 |
BlackRock
New York
|
+$905 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.15M |
| 2 |
Jane Street
New York
|
-$262K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$36.6K |
| 4 |
Morgan Stanley
New York
|
-$18.4K |
| 5 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$10K |
ZEAL Hedge Fund Activity: Q2 2021 in Review
16 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q2 2021, worth a combined $39.5M — down 18% from $47.9M a quarter earlier.
Fund positioning in ZEAL was balanced in Q2 2021: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 6 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $393K. The largest seller was Wellington Management Group, cutting an estimated $5.15M.
- 16 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $39.5M of Zealand Pharma A/S American Depositary Shares stock for Q2 2021, down 18% quarter-over-quarter.
- 3 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q2 2021 and 3 closed out, a net change of 0 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q2 2021 was Old Mission Capital, an estimated $393K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q2 2021 was Wellington Management Group, an estimated $5.15M sold.
Based on aggregated 13F filings for Q2 2021.